10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
46.27
-1.79 (-3.72%)
At close: Jul 24, 2026, 4:00 PM EDT
46.01
-0.26 (-0.56%)
After-hours: Jul 24, 2026, 7:57 PM EDT

10x Genomics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
638.78642.82610.79618.73516.41490.49
Revenue Growth
2.26%5.24%-1.28%19.81%5.28%64.13%
Gross Profit
444.61443.88414.48409.31396.02416.4
Operating Income
-38.7-60.99-194.56-265.33-167.94-52.25
Net Income
-22.66-43.54-182.63-255.1-166-58.22
Earnings Per Share
-0.17-0.35-1.52-2.18-1.46-0.53
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Single Cell Instruments
21.9822.6735.2147.8758.5564.17
Spatial Instruments
31.2534.1157.575.6113.840.3
Single Cell Consumables
367.99363.21372.31420.32400.43390.88
Spatial Consumables
153.64143.98121.1259.2435.1627.86
Services
33.9132.7324.3215.78.437.28
License and Royalty
30.0246.140.32---
Revenue (Total)
638.78642.82610.79618.73516.41490.49

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
539.85523.41393.4388.7432.62588.48
Total Debt
81.3984.3682.6195.3795.1881.98
Net Cash (Debt)
458.46439.05310.79293.33337.44506.5
Net Cash Growth
32.19%41.27%5.95%-13.07%-33.38%-17.94%
Net Cash Per Share
3.633.522.582.502.964.59

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
127.82136.056.66-15.2-33.61-21.37
Capital Expenditures
-5.64-5.94-12.39-48.6-131.66-101.28
Free Cash Flow
122.18130.12-5.73-63.8-165.27-122.65
Free Cash Flow Growth
169.33%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
69.60%69.05%67.86%66.15%76.69%84.89%
Operating Margin
-6.06%-9.49%-31.85%-42.88%-32.52%-10.65%
Pretax Margin
-3.01%-6.21%-29.09%-40.21%-31.36%-10.95%
Profit Margin
-3.55%-6.77%-29.90%-41.23%-32.15%-11.87%
FCF Margin
19.13%20.24%-0.94%-10.31%-32.00%-25.01%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
48.0816.01----
PS Ratio
9.203.242.8810.778.1333.93